SELECTIVE INDUCIBLE NITRIC OXIDE SYNTHASE INHIBITION DURING LONG-TERM HYPERDYNAMIC PORCINE BACTEREMIA
- 1 May 2004
- journal article
- research article
- Published by Wolters Kluwer Health in Shock
- Vol. 21 (5) , 458-465
- https://doi.org/10.1097/00024382-200405000-00010
Abstract
We have recently demonstrated that selective inducible nitric oxide (NO) synthase (iNOS) inhibition with 1400W attenuated the hemodynamic and metabolic alterations affiliated with hyperdynamic porcine endotoxemia. In contrast to endotoxemia, limited evidence is available to document a relationship between NO and organ dysfunction in large animal bacteremic models. Therefore, using the same experimental setup, we investigated the role of selective iNOS blockade in porcine bacteremia induced and maintained for 24 h with a continuous infusion of live Pseudomonas aeruginosa. After 12 h of sepsis, animals received either vehicle (Control, n = 8) or continuous infusion of selective iNOS inhibitor, L-N6-(1-iminoethyl)-lysine (L-NIL; n = 8). Measurements were performed before, and 12, 18, and 24 h after P. aeruginosa infusion. L-NIL inhibited sepsis-induced increase in plasma nitrate/nitrite concentrations and prevented hypotension without affecting cardiac output. Despite comparable hepatosplanchnic macrocirculation, L-NIL blunted the progressive deterioration in ileal mucosal microcirculation and prevented mucosal acidosis. L-NIL largely attenuated mesenteric and hepatic venous acidosis, significantly improved P. aeruginosa-induced impairment of hepatosplanchnic redox state, and mitigated the decline in liver lactate clearance. Furthermore, the administration of L-NIL reduced the hepatocellular injury and prevented the development of renal dysfunction. Finally, treatment with L-NIL significantly attenuated the formation of 8-isoprostane concentrations, a direct marker of lipid peroxidation. Thus, selective iNOS inhibition with L-NIL prevented live bacteria from causing key features of metabolic derangements in porcine hyperdynamic sepsis. Underlying mechanisms probably include reduced oxidative stress with improved microcirculatory perfusion and restoration of cellular respiration.Keywords
This publication has 34 references indexed in Scilit:
- Is nitric oxide overproduction the target of choice for the management of septic shock?Pharmacology & Therapeutics, 2001
- EFFECTS OF SELECTIVE iNOS INHIBITION ON GUT AND LIVER O2-EXCHANGE AND ENERGY METABOLISM DURING HYPERDYNAMIC PORCINE ENDOTOXEMIAShock, 2001
- Effects of Nitric Oxide in Septic ShockAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Increased Microvascular Reactivity and Improved Mortality in Septic Mice Lacking Inducible Nitric Oxide SynthaseCirculation Research, 2000
- Expired nitric oxide and shock in higher order speciesCritical Care Medicine, 1999
- SELECTIVE INHIBITION OF THE ACTIVITY OF INDUCIBLE NITRIC OXIDE SYNTHASE PREVENTS THE CIRCULATORY FAILURE, BUT NOT THE ORGAN INJURY/DYSFUNCTION, CAUSED BY ENDOTOXINShock, 1998
- The multiple organ dysfunction syndrome caused by endotoxin in the rat: attenuation of liver dysfunction by inhibitors of nitric oxide synthaseBritish Journal of Pharmacology, 1995
- Beneficial effects and improved survival in rodent models of septic shock with S-methylisothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase.Proceedings of the National Academy of Sciences, 1994
- Nitric oxide‐mediated hyporeactivity to noradrenaline precedes the induction of nitric oxide synthase in endotoxin shockBritish Journal of Pharmacology, 1993
- Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharides in the rat in vivoEuropean Journal of Pharmacology, 1990